Shaping Microbiome R&D's Future: Is Big Pharma Missing The Boat?

The White House said the Obama administration plans to spend $121m under a new initiative to push the science of the microbiome forward. But few drug makers were among those who responded to the administration's call to action to support the initiative's overarching goals.